Sage Therapeutics, Inc. (SAGE) Ownership

$8.68

south_east
-$0 (0%)
Day's range
$8.68
Day's range
$8.68

Sage Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MADISON AVENUE PARTNERS, LP 08/14/2025 6.08 M $55.42 M   35.72% 9.71%
BLACKROCK, INC. 08/12/2025 4.55 M $41.45 M   -2.48% 7.26%
VANGUARD GROUP INC 08/11/2025 3.27 M $29.78 M   -35.68% 5.22%
HUDSON BAY CAPITAL MANAGEMENT LP 08/18/2025 1.95 M $17.80 M   236.84% 3.12%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2025 1.52 M $13.85 M   1,234.90% 2.42%
GEODE CAPITAL MANAGEMENT, LLC 08/08/2025 1.36 M $12.37 M   4.08% 2.17%
ALPINE ASSOCIATES MANAGEMENT INC. 08/05/2025 1.27 M $11.61 M   100.00% 2.03%
STATE STREET CORP 08/14/2025 1.17 M $10.63 M   -1.90% 1.86%
683 CAPITAL MANAGEMENT, LLC 08/14/2025 1.15 M $10.49 M   15.00% 1.84%
MARSHALL WACE, LLP 08/13/2025 1.15 M $10.47 M   -34.86% 1.83%
RENAISSANCE TECHNOLOGIES LLC 08/13/2025 1.11 M $10.15 M   44.65% 1.78%
TORONTO DOMINION BANK 08/14/2025 1.08 M $9.87 M   100.00% 1.73%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2025 1.08 M $9.87 M   100.00% 1.73%
MILLENNIUM MANAGEMENT LLC 08/14/2025 1.00 M $9.14 M   223.94% 1.60%
HARVEST MANAGEMENT LLC 08/14/2025 889.20 K $8.11 M   22.45% 1.42%
DIMENSIONAL FUND ADVISORS LP 08/12/2025 874.17 K $7.97 M   81.45% 1.40%
RANGELEY CAPITAL, LLC 08/14/2025 730.00 K $6.66 M   89.76% 1.17%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2025 721.60 K $6.58 M   -2.81% 1.15%
NEWTYN MANAGEMENT, LLC 08/14/2025 700.00 K $6.38 M   100.00% 1.12%
BOUSSARD & GAVAUDAN INVESTMENT MANAGEMENT LLP 08/19/2025 614.94 K $5.61 M   -6.21% 0.98%
JACOBS LEVY EQUITY MANAGEMENT, INC 08/14/2025 581.75 K $5.31 M   -17.64% 0.93%
NUVEEN, LLC 08/12/2025 555.04 K $5.06 M   -7.23% 0.89%
NORTHERN TRUST CORP 08/13/2025 462.59 K $4.22 M   -1.17% 0.74%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/12/2025 458.25 K $4.18 M   2.71% 0.73%
GLAZER CAPITAL, LLC 08/14/2025 441.11 K $4.02 M   100.00% 0.70%
OMERS ADMINISTRATION CORP 08/13/2025 424.30 K $3.87 M   100.00% 0.68%
AQR ARBITRAGE LLC 08/14/2025 409.06 K $3.73 M   100.00% 0.65%
MONACO ASSET MANAGEMENT SAM 08/07/2025 366.62 K $3.34 M   -16.98% 0.59%
HRT FINANCIAL LP 08/14/2025 330.66 K $3.02 M   119.97% 0.53%
EISLER CAPITAL MANAGEMENT LTD. 08/12/2025 330.15 K $3.01 M   94.21% 0.53%
Y-INTERCEPT (HONG KONG) LTD 08/01/2025 303.89 K $2.77 M   100.00% 0.49%
BCK CAPITAL MANAGEMENT LP 08/07/2025 297.04 K $2.71 M   100.00% 0.47%
DECAGON ASSET MANAGEMENT LLP 08/14/2025 292.00 K $2.66 M   100.00% 0.47%
JUMP FINANCIAL, LLC 08/13/2025 289.34 K $2.64 M   53.42% 0.46%
TWO SIGMA INVESTMENTS, LP 08/14/2025 268.01 K $2.44 M   -25.22% 0.43%
FEDERATED HERMES, INC. 08/13/2025 246.80 K $2.25 M   -79.30% 0.39%
GABELLI & CO INVESTMENT ADVISERS, INC. 08/13/2025 224.45 K $2.05 M   100.00% 0.36%
TREXQUANT INVESTMENT LP 08/12/2025 223.12 K $2.03 M   -64.79% 0.36%
DEUTSCHE BANK AG\ 08/12/2025 215.91 K $1.97 M   -3.61% 0.34%
WALLEYE TRADING LLC 08/13/2025 206.30 K $1.88 M   100.00% 0.33%
GABELLI FUNDS LLC 08/13/2025 200.78 K $1.83 M   100.00% 0.32%
INVESCO LTD. 08/13/2025 200.33 K $1.83 M   23.29% 0.32%
TWO SIGMA ADVISERS, LP 08/14/2025 198.80 K $1.81 M   -38.83% 0.32%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 08/14/2025 196.28 K $1.79 M   -7.22% 0.31%
CUBIST SYSTEMATIC STRATEGIES, LLC 08/14/2025 192.26 K $1.75 M   100.00% 0.31%
VERITION FUND MANAGEMENT LLC 08/14/2025 184.45 K $1.68 M   7.22% 0.29%
BANK OF NEW YORK MELLON CORP 08/05/2025 183.01 K $1.67 M   5.95% 0.29%
YAKIRA CAPITAL MANAGEMENT, INC. 08/13/2025 182.63 K $1.67 M   100.00% 0.29%
JANE STREET GROUP, LLC 08/14/2025 179.62 K $1.64 M   -7.02% 0.29%
AMERIPRISE FINANCIAL INC 08/14/2025 169.86 K $1.55 M   158.70% 0.27%

Sage Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 269 institutional investors and hedge funds held shares of Sage Therapeutics, Inc.. The most heavily invested institutionals were:

UBS Group AG: 0

Mariner, LLC: 0

ProShare Advisors LLC: 0

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC: 0

NEW YORK STATE COMMON RETIREMENT FUND: 0

PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO: 0

71.56% of Sage Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 21.10 M shares in the last 24 months. This purchase volume represents approximately $183.11 M in transactions.